Radiopharm Theranostics RADX Growth Metrics (2024-2026)

NASDAQ RADX
$1.44 -0.18 (-11.11%)
As of: Oct 1, 2026 · 10:36 AM EDT
Reported Financials

Radiopharm Theranostics Quarterly Growth Metrics

Periods 3 quarters
Latest Jun 2026

Radiopharm Theranostics reported asset growth of -22.98% for the quarter ended Jun 2026. These growth metrics cover 3 quarters of results from Jun 2024 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Radiopharm Theranostics Growth Metrics API

Pull Radiopharm Theranostics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=RADX&statement=Growth&frequency=Quarter&period=all&api_key=YOUR_API_KEY